Cite Filings / NRIX / 0001104659-24-007679
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13G

Amended Statement of Ownership

Nurix Therapeutics, Inc. · Filed 2024-01-29 · Acc 0001104659-24-007679

Documents 1

  • SC 13G Amended Statement of Ownership , tm244117d1_sc13g.htm

Around this filing

  • 2024-02-09 SC 13G Amended Statement of Ownership
  • 2024-01-30 4 Chief Financial Officer sold 1,671 shares at $7.99 ($13,352)
  • 2024-01-30 4 Chief Scientific Officer sold 2,334 shares at $7.99 ($18,649)
  • 2024-01-30 4 Chief Legal Officer sold 1,760 shares at $7.99 ($14,063)
  • 2024-01-29 SC 13G Amended Statement of Ownership
  • 2024-01-24 SC 13G/A Amended Statement of Ownership
  • 2023-02-24 SC 13G Amended Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · Perceptive Advisors LLC 4.9%
  2. 2026-11-16 SCHEDULE 13G/A · Deep Track Capital, LP 5.49%
  3. 2026-11-16 SCHEDULE 13G/A · Rubric Capital Management LP 4.55%
  4. 2026-11-16 SCHEDULE 13G/A · Vestal Point Capital, LP 6.4%
  5. 2026-11-16 SCHEDULE 13G/A · T. Rowe Price Associates, Inc. 4.4%
Loading tm244117d1_sc13g.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…